Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 114.46B | 115.11B | 113.51B | 107.85B | 98.15B | 218.35B |
Gross Profit | 56.92B | 53.30B | 55.63B | 53.44B | 48.29B | 49.45B |
EBITDA | 8.73B | 10.17B | 9.63B | 7.51B | 5.26B | 3.02B |
Net Income | 2.96B | 3.48B | 2.78B | 1.89B | -775.00M | -4.95B |
Balance Sheet | ||||||
Total Assets | 119.93B | 114.39B | 115.36B | 118.34B | 119.38B | 123.42B |
Cash, Cash Equivalents and Short-Term Investments | 3.69B | 2.59B | 3.73B | 3.24B | 4.10B | 5.62B |
Total Debt | 4.51B | 4.62B | 6.04B | 12.58B | 16.84B | 17.22B |
Total Liabilities | 83.81B | 75.81B | 78.05B | 83.76B | 86.07B | 89.78B |
Stockholders Equity | 36.11B | 38.58B | 37.32B | 34.59B | 33.31B | 33.64B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.79B | 6.59B | 4.67B | -1.12B | 146.00M |
Operating Cash Flow | 0.00 | 6.73B | 10.17B | 7.56B | 2.50B | 4.30B |
Investing Cash Flow | 0.00 | -3.90B | -2.19B | -3.02B | -3.30B | -3.61B |
Financing Cash Flow | 0.00 | -3.97B | -7.49B | -5.40B | -715.00M | 1.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥514.57B | 12.41 | 10.25% | 2.24% | 8.72% | 19.26% | |
71 Outperform | €235.12B | 6.52 | 11.92% | 2.07% | 3.71% | 64.27% | |
70 Outperform | ¥786.37B | 15.12 | 8.71% | 2.79% | 3.56% | -2.54% | |
68 Neutral | $333.32B | 10.04 | 7.14% | 2.38% | 2.11% | -4.24% | |
67 Neutral | ¥253.34B | 13.18 | 6.44% | 2.78% | 5.06% | -11.83% | |
57 Neutral | ¥54.12B | 22.71 | 1.76% | 16.65% | -9.43% | ||
55 Neutral | ¥70.09B | 19.76 | 1.15% | 1.41% | 27.48% |